(This story is part of the cover package in the July issue of MJBizMagazine.)
Long restricted by the federal government and stigmatized by the medical and scientific communities, cannabis has been involved in only a handful of studies carried out in the United States over the past several decades.
The overwhelming majority of cannabis studies undertaken by universities, pharmaceutical companies and other entities – and frequently funded by the canna-skeptical National Institute on Drug Abuse and the National Institutes of Health – have focused on addiction and impairment, impact on teens and other potentially negative consequences of cannabis.
ADVERTISEMENT
But federal agencies such as the Drug Enforcement Administration and the Food and Drug Administration – while not exactly smoking blunts with NORML on the frontlines of legalization – are not the anti-marijuana zealots they were only a decade ago.
DEA expands licenses
The DEA, for example, has in the
Read full article on Marijuana Business Daily